Beyond Insulin Escalation: REIMAGINE 3 & Advanced T2D Care Clinical Reference Card for Master in Internal Medicine Exam Preparation 🎯 EXECUTIVE SUMMARY The REIMAGINE 3 trial (Rosenstock et al., The…
Cagrilintide–Semaglutide (CagriSema) as Add-on to Basal Insulin in T2D REIMAGINE 3: A Phase 3, Randomised, Double-Blind, Placebo-Controlled Trial The Lancet | Specialty: Endocrine-Metabolic | 2024 …
SUCCESSOR-2: Mezigdomide in Relapsed/Refractory Multiple Myeloma A Clinical Reference Card for Master in Internal Medicine 🎯 EXECUTIVE SUMMARY The SUCCESSOR-2 trial, a pivotal phase 3, open-label, …